Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to ...

Skin cancers, lung cancers, lymphomas—though these cancers affect different parts of the body, they can all be treated with one of the latest therapies medicine has to offer: checkpoint inhibitors.

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

Host-Related Determinants of Immunotherapy Response in NSCLC may include obesity, sarcopenia, metabolic comorbidities, sex, ...

When many cancers advance, spread and reoccur, checkpoint inhibitors can help keep difficult tumors at bay. These antibody-based immunotherapies can restore the body’s ability to recognize and ...

Scientists are closing in on a deceptively simple idea with radical implications: that a single protein signal in the blood ...

Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...

Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...

Please provide your email address to receive an email when new articles are posted on . Adding immune checkpoint inhibitors to neoadjuvant chemotherapy benefited certain patients with early-stage ...